Fred Hutchinson Cancer Research Center Multiomic Study Points to New Colorectal Cancer Risk Contributors Researchers tracked down more than 100 new risk variants with a combination of genomic, transcriptomic, and methylation analyses, highlighting new and known risk pathways. Breast, Ovarian Cancer Study Finds Ties Between Types of BRCA Alterations, Treatment Response Breast and ovarian cancers with BRCA1 promoter methylation changes showed poorer chemotherapy responses than those with genetic alterations in BRCA1 or BRCA2. CellCarta Acquires Rights to Targeted Protein Assays from Fred Hutch Spinout Precision Assays Precision Assays' immuno-MRM mass spectrometry assays use antibody enrichment of protein targets followed by mass spec analysis to quantify proteins of interest. EpiCypher Licenses Chromatin Profiling Technologies From Fred Hutchinson Cancer Center The technologies, licensed co-exclusively, can be used to study histone post-translational modifications and chromatin-associated proteins. Machine Learning Method Allows Highly Multiplexed Cell Surface Protein Analysis via Flow Cytometry Premium The method could offer a more accessible, less expensive way to measure the expression of hundreds of cell surface markers across millions of single cells. Apr 21, 2021 Red Blood Cell Traits Linked to New Loci With Whole-Genome Sequencing Data Jan 6, 2021 TwinStrand Biosciences Explores Error Reduction Sequencing Tech in Various Applications Premium Nov 25, 2020 Pediatric Brain Tumor Proteomics Highlight Possible Treatment Targets, Biomarkers Nov 11, 2020 Adaptive Biotechnologies Prepares to Launch T Cell-Based COVID-19 Test Premium Sep 11, 2020 Genomic Epidemiology Studies Retrace Sources of Early SARS-CoV-2 Outbreaks in US, Europe Apr 13, 2020 SARS-CoV-2 Genomes Let Researchers Retrace Viral Spread, Mitigation Effects Apr 7, 2020 Multiomic Approach Measures Protein Expression, RNA Transcript Levels of Single Cells Feb 20, 2020 Lucid Diagnostics, Fred Hutchinson Cancer Research Center Ink Esophageal Cancer Biomarker Deal Oct 10, 2019 Mission Bio Lands $2M NCI SBIR Grant to Advance Minimal Residual Disease Detection Oct 2, 2019 SEngine Precision Medicine Raises $5.1M in Series A Financing Jul 18, 2019 Immune Response Dampened in Many Cancers by Reactivation of Embryonic Gene May 30, 2019 New Studies Examine Genetic, Environmental Risk Factors Linked to Lung Cancer Among Never Smokers Premium May 9, 2019 Broad Aims for Portable Pipeline as It Readies AWS-Compatible Version of Cromwell Premium Apr 4, 2019 Epigenetic Therapies May Prime Tumors to Better Respond to Other Treatments, AACR Speakers Say Dec 3, 2018 Colorectal Cancer Risk Linked to Common, Rare Variants Nov 9, 2018 National Cancer Institute Awards $4M to Brain Tumor Sequencing Projects Nov 6, 2018 BGI, Fred Hutchinson Sign Collaboration MOU Dec 6, 2017 Brotman Baty Institute for Precision Medicine Launched With $50M Funding Jul 11, 2017 SEngine Precision Medicine's Lab Garners CLIA Certification Jul 6, 2017 SEngine Precision Medicine Licenses Hutch Cancer Drug Screening Assay Load More Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.